BCG's 2024 report found that 83% of senior executives call innovation a top-three priority. But only 3% of their companies qualify as innovation-ready. That's down from 20% just two years earlier.
The gap isn't shrinking. It's growing.
We see this pattern across many enterprise innovation programs. Not a lack of effort, but a misalignment between what gets measured and what actually drives progress. Organizations have added dashboards, hired analysts, built reporting layers. The result is more measurement — but less experimentation. And less learning.
The problem isn't that measurement is happening. It's that most innovation programs still measure output when they should be measuring learning.
Three metrics that predict breakthroughs
Most organizations track idea volume, patents filed, or project-level ROI. These aren't useless signals. But they focus on activity — things that already happened. They don't tell you whether innovation capacity is growing.
What actually predicts breakthroughs looks different.
They shape how innovation happens.
What the Post-it Note taught us about approval chains
Here's a pattern we keep seeing in large organizations: for an idea to move forward, it has to pass through layer after layer of approval.
Multiple chances to say "no." One final "yes" required at the end.
The intention behind this is quality control. The outcome is often the opposite: stalled progress.
The Post-it Note — one of 3M's most successful products — was rejected internally for years. No clear market. No proven ROI. No obvious fit.
It didn't succeed because the hierarchy approved it. It succeeded because people started using it anyway. Informal networks created traction where formal processes couldn't.
And this pattern still exists today.
From approval chains to portfolio thinking
Venture capital figured out decades ago that most individual bets won't pay off. Across thousands of startups, roughly 60% fail to return investment. Only a small fraction generates the majority of all returns.
VCs don't measure each deal by individual ROI. They measure portfolio learning velocity — how fast does each outcome improve the next decision.
Most enterprise innovation programs do the opposite. Every idea is treated as a standalone P&L. Anything that can't show returns within a set period gets cut. The result: the portfolio never learns. It just cycles through disconnected bets.
Organizations making innovation work are shifting their approach: away from rigid approval chains, toward portfolio thinking.
Because not every idea needs to succeed on its own. What matters is whether the system learns fast enough — across all of them — to find the ones that do.
| What most teams track | What actually compounds |
|---|---|
| Patents filed per year | Revenue from products less than 5 years old |
| Ideas in the pipeline | Experiments that build on prior results |
| Innovation budget spent | Learning velocity — experiments per dollar |
| Project completion rate | Portfolio learning rate — whether failures improve future outcomes |
What this means in practice
None of this requires throwing out existing metrics. ROI still matters. Pipeline management still matters. But these are lagging indicators. They tell you what already happened.
The shift is adding leading indicators alongside them: collision rate, experiment velocity, knowledge compounding. These are the metrics that predict whether innovation capacity is building — or eroding.
A practical starting point: run a dual dashboard. Leading indicators for the innovation team. Lagging indicators for the board. Once leadership sees how the leading metrics correlate with the outcomes they care about, the conversation changes.
The infrastructure matters too. Collisions don't happen reliably by accident. Experiments don't scale without systems that connect the right people, capture what's learned, and make it reusable. Compounding requires continuity — and continuity requires a platform designed for it.
That's where innovation software earns its place. Not as a suggestion box. Not as a reporting layer. As the connective tissue that makes cross-functional collaboration, rapid experimentation, and knowledge reuse a default part of how innovation works.
